247 A phase III trial of recombinant granulocyte-macrophage colony stimulating factor (GM-CSF) as corrective treatment in patients (PTS) with neutropenic fever following antineoplastic chemotherapy (CT): Results of an intermediate analysis
Year: 1995
Type: article
Source: European Journal of Cancer
Institutions: Institut Bergonié, Institut Claudius Regaud
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2073674293